AAytesLab

2.4K posts

AAytesLab banner
AAytesLab

AAytesLab

@AAytesLab

Investigating mechanisms of prostate cancer therapeutic resistance at @IDIBELL and @ICOnoticies.

Barcelona, España Katılım Ağustos 2016
1.5K Takip Edilen1.4K Takipçiler
AAytesLab
AAytesLab@AAytesLab·
#HappyBirthday dear #brother! 50 and counting stronger than ever. You are a blessing and the purest form of love I’ve ever known. No wonder Mom and Dad named you Àngel. You make this ugly and selfish world a better place. Love you!
AAytesLab tweet mediaAAytesLab tweet media
English
1
1
14
748
AAytesLab
AAytesLab@AAytesLab·
Hoy me han llamado a mi número particular para pedirme dinero para el proyecto de la triple terapia contra el cáncer de páncreas…. No hace falta decir qué fundación me ha llamado ni quien dirige el proyecto… no salgo de mi asombro… con la que está cayendo…
Español
1
0
6
1.2K
AAytesLab
AAytesLab@AAytesLab·
🙌🏻
Dr. Filippo Cademartiri@FCademartiri

This article should be mandatory reading for every medical student, PhD candidate, researcher—and honestly, for anyone who mistakes expertise for certainty. “The importance of stupidity in scientific research” sounds provocative, almost offensive. But Martin Schwartz is not glorifying incompetence. He is describing the real operating system of discovery. Science is not built on knowing. Science is built on tolerating not knowing. That distinction matters. Most of education rewards correctness. School teaches us to answer. Exams reward speed, certainty, and precision. You feel intelligent when you get things right. Research is the opposite. Real research begins exactly where competence ends—at the frontier where nobody knows the answer, including the people you thought must know. That moment is psychologically brutal. You ask the expert. The expert shrugs. You assume you’re missing something. Then you realize: no—this is the work. You are not failing. You are standing at the actual boundary of knowledge. That feeling—“I must be stupid”—is often not a sign of inadequacy. It is often the first sign that you are finally asking an important question. Medicine struggles with this. We train doctors to avoid uncertainty, to fear being wrong, to perform confidence. But the best clinicians and the best scientists know how to sit inside ambiguity without collapsing into fake certainty. This is why AI in medicine also deserves caution. Systems trained only to reproduce established answers may become extraordinarily good at passing exams while being terrible at discovering what matters next. Guideline intelligence is not the same as scientific intelligence. Discovery requires productive stupidity: the willingness to stay with the uncomfortable, to look ignorant, to ask naïve questions, to be wrong repeatedly without protecting your ego. Most people want the authority of expertise. Very few want the humiliation required to earn it. But progress lives there. Not in certainty. Not in performance. Not in sounding smart. In the quiet discipline of saying: “I don’t know… yet.” And continuing anyway.

ART
0
0
2
217
Ester Calvo Fernandez
Ester Calvo Fernandez@EsterCalvoFern·
🚨Publication alert🚨 My first-author PhD paper is out today in Nature Genetics nature.com/articles/s4158… Tumors aren’t one entity — they’re made of coexisting cell states with distinct vulnerabilities. We show that targeting complementary states simultaneously in DMG is key.
English
9
42
228
17.1K
AAytesLab
AAytesLab@AAytesLab·
Que el ministerio o las CCAA paguen (poco pero algo) por revisar protectos y las fundaciones privadas no, me lo tiene que explicar alguien…. El argumento de que son donaciones es malo, muy malo….
Español
0
0
3
214
Xose R Bustelo
Xose R Bustelo@XRBustelo·
Qué facilidad de decir cosas ocultándose bajo pseudónimos. Y para ser un ignorante sin sentimientos hacia una, sí, paciente de mamá. Y que, a pesar de sus problemas, ha seguido trabajando para hacer un mundo mejor. Me congratulo que usted sepa escribir, pena que no sepa leer
Español
1
0
22
3.5K
AAytesLab
AAytesLab@AAytesLab·
@manuelansede @iguardans no todos los medios tienen una sección especializada como la vuestra y a muchos les va el sensacionalismo y tratar estos temas como “salseo” science-Pop. Se impone una reflexión colectiva, científicos, financiadores, centros de investigación y periodistas.
Español
0
0
1
58
Manuel Ansede
Manuel Ansede@manuelansede·
@iguardans Crees mal, Ignasi. La empresa de Barbacid dice lo mismo que El Hormiguero. Por eso hay cientos de personas con cáncer escribiendo desesperadamente al CNIO, porque se han hinchado unos resultados prometedores en ratones de manera irresponsable:
Manuel Ansede tweet mediaManuel Ansede tweet media
Español
3
7
28
2.3K
Ignasi Guardans
Ignasi Guardans@iguardans·
Creo que los medios están presentando como una rectificación de Barbacid sobre supuestas exageraciones… lo que solo fueron faltas graves por parte de la propia prensa que ahora lo denuncia. Las exageraciones no estaban en la fuente: las hicieron otros al informar.
EL PAÍS@el_pais

La empresa del bioquímico Mariano Barbacid proclamaba a toda pantalla en su página web —hasta este viernes— que han logrado “la primera terapia efectiva contra el cáncer de páncreas”, pero el eslogan está lejos de ser cierto social.elpais.com/0wwsu5

Español
13
30
136
14.2K
AAytesLab retweetledi
Alejo Rodriguez-Fraticelli, PhD
Alejo Rodriguez-Fraticelli, PhD@AlejoFraticelli·
There’s a now generation of very good scientists in Spain that are the product of a golden age in public universities, where many talented Spanish researchers returned to in the 80/90s and dedicated themselves to teaching. With the lack of current Uni funding, it may be the last.
English
0
11
66
5.1K
AAytesLab
AAytesLab@AAytesLab·
@AlejoFraticelli Agree and we should all support those who try. And that’s compatible with asking for a responsible communication that explains both breakthroughs and limitations.
English
1
1
2
273
Alejo Rodriguez-Fraticelli, PhD
Alejo Rodriguez-Fraticelli, PhD@AlejoFraticelli·
🇺🇸 “We’re creating superintelligence” - Here’s 1 trillion dollars from literally everyone 🇪🇸“We may cure pancreatic cancer” - We’re being careless with people’s expectations With this mentality, we can’t compete. Can we all agree that *failing is ok, but trying is essential?*
English
3
1
20
3.1K
AAytesLab
AAytesLab@AAytesLab·
Comunicación sencila, clara, honesta que pone de relieve los grandes avances sin generar expectativas que llevan a frustración primero y desconfianza después. 👇🏻
Simon Maechling@simonmaechling

Now that everyone is an expert on curing pancreatic cancer in mice, not rats - I want to add some context that goes beyond the headline. You will want to read this. Cancer is cured in mice all the time. Thousands of times. ~90% of those “cures” fail in humans. Why? Because mice are: Genetically simpler. Treated earlier. Short-lived. Not humans. Mice are a filter - not a finish line. Yes, this study matters. It comes from the Spanish National Cancer Research Centre. Yes, it’s pancreatic cancer - one of the deadliest there is. Yes, full tumor regression is impressive. But here’s what it actually means: “This approach is now good enough to risk years, trials, and millions of euros on.” Not: “Cancer is solved.” What happens next? More animal work. Toxicology. Phase I (safety). Phase II (maybe works). Phase III (beats standard care?). Maybe 8-10 years if everything goes right. The real damage isn’t failed drugs. It’s failed expectations. Every “cured cancer in mice” headline trains the public to believe: Cures are being hidden. Progress should be fast. Scientists are lying when reality hits. That’s how trust erodes. Bottom line: This is how real cancer progress looks. Messy. Slow. Risky. Incremental. Not miracles. Not conspiracies. Just science - doing the hard work.

Español
0
2
5
427
AAytesLab
AAytesLab@AAytesLab·
Por los pacientes y sus familiares, para no abundar en su frustración y sus miedos, igual hay que replantear la communicación de la investigación biomédica…. Un poco de prudencia no estaría de más.
Español
3
17
51
6.9K
Douglas Yao
Douglas Yao@DouglasYaoDY·
@MaxUnfried @klapka91 @kedartv @bryan_johnson IMO that’s exactly the use case where you would want high-quality reproducible training data, which is impossible to generate from current cell lines. Alphafold only works because the training data was high quality.
English
2
0
2
803
Douglas Yao
Douglas Yao@DouglasYaoDY·
Peter Thiel said that the lack of progress in biology is partially due to a lack of talent. I think this makes sense. Something about biology's non-technical nature + people's inability to tinker w/biology outside of a lab/PhD make the smartest people select other fields.
English
467
166
3.8K
1.2M
Lluis Montoliu
Lluis Montoliu@LluisMontoliu·
@manuelansede nos recuerda la histórica batalla interpretativa sobre cómo estaba organizado el sistema nervioso. Golgi pensaba que todas las neuronas estaban unidas (teoría reticular), Cajal pensaba que cada neurona era independiente (teoría neuronal), pero comunicada. Acertó.
Español
1
0
6
695
Lluis Montoliu
Lluis Montoliu@LluisMontoliu·
Golgi y Cajal, dos neurocientíficos que interpretaron de forma opuesta las imágenes que veían al microscopio de neuronas teñidas por un método creado por el primero. Golgi las veía unidas, Cajal independientes. Nobel para los dos @manuelansede en @el_pais elpais.com/ciencia/2025-0…
Español
3
42
129
7.6K